STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Stoke Therapeutics, Inc.

Filed

December 27, 2024

Period of Report

December 23, 2024

Accession Number

0001062993-24-021228